Phase II Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms AIO-TEX; TEX
- 20 Dec 2012 Status changed from active, no longer recruiting to completed.
- 23 Mar 2011 Planned end date changed from 1 Dec 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 23 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.